Suppr超能文献

[钙拮抗剂对糖尿病患者碳水化合物及脂质代谢的影响]

[The effect of calcium antagonists on carbohydrate and lipid metabolism in diabetes mellitus].

作者信息

Morugova T V, Kamilov F Kh, Lazareva D N

出版信息

Eksp Klin Farmakol. 1993 Mar-Apr;56(2):37-9.

PMID:8348037
Abstract

The effect of calcium antagonists: nifedipine (corinfar, cordapheg), sensit, finoptin, foridon on carbohydrate and lipid metabolism was studied in intact and "alloxaned" rats as well as in non-insulin-dependent diabetes patients. It was found that the calcium channel blockers did not change glucose tolerance, normalized carbohydrate metabolism in some patients and decreased the level of triglycerides, B and pro-B lipoproteins. In some cases in intact and alloxane rats treated with finophin (isoptin), lactate decrease in blood and a tendency to insulin increase were often observed. The lipid metabolism was unchanged.

摘要

研究了钙拮抗剂硝苯地平(心痛定、可心定)、硫氮䓬酮、氟桂利嗪、福里多对正常及“四氧嘧啶糖尿病”大鼠以及非胰岛素依赖型糖尿病患者碳水化合物和脂质代谢的影响。结果发现,钙通道阻滞剂并未改变葡萄糖耐量,使部分患者的碳水化合物代谢恢复正常,并降低了甘油三酯、β脂蛋白和前β脂蛋白水平。在用硫氮䓬酮(异搏定)治疗的正常及四氧嘧啶糖尿病大鼠中,某些情况下常观察到血液中乳酸水平降低以及胰岛素水平有升高趋势。脂质代谢未发生变化。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验